Stock Updates

Morning Hot Stocks: Abbott Laboratories, (ABT)

Friday February 24th 2017: Abbott Laboratories, ABT is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Abbott Laboratories, ABT  has a market cap of 85.9 B. Since its IPO date on the 04/06/1983, Abbott Laboratories, ABT performance year to date is 26.09%. Today Abbott Laboratories, ABT has gained -0.35%, with a current price of 48.26.

Ownership of the company is 0.70% for insider ownership while institutional ownership is 73.50%. The management of the company have seen the company have a payout ratio of 107.00%. Return of assets are at 3.00%, with return on investment at 6.70%.

In terms of debt levels and profit levels, Abbott Laboratories, ABT is seeing a long-term debt/equity of 0.76. While Total debt/equity is 0.76. With a profit margin of 6.70%, this is combined with a gross margin of 55.50%, and operating margin of 11.00%. Abbott Laboratories ability to meet debt levels, with a current ratio of 2.9, while the quick ratio is 2.3.

For the last year Abbott Laboratories, ABT has seen a EPS growth of -58.60%. A performance for the year of 14.03%. The 52-week high is -2.68%, and the 52-week low is 29.11%. The average volume for Abbott Laboratories, ABT is 3275861.

With a target price of 50.47, can Abbott Laboratories, ABT reach this target? Looking at the value indicators of Abbott Laboratories, ABT. Abbott Laboratories has a P/E of 53.75 and a forward P/E of 17.59. Perhaps the more useful indicator than P/E, is PEG which has a value of 4.86. Abbott Laboratories also has a P/S and a P/B of 3.85 and 2.67 respectively. For P/cash, Abbott Laboratories has a value of 9.69, while it is 77.66 for P/free cash flow.

At the current price of 48.26, Abbott Laboratories has a dividend yield of 2.19%. We see a return on equity of 6.40%.

Looking more long-term Abbott Laboratories, is projected to get an EPS growth for the next five years of 11.06%. In the short-term an EPS growth of 11.68% in the next year is forecasted. This is after a EPS growth of -58.60% for this year and for the last five years a 0.00% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment